单兆伟教授治疗胃癌术后临床经验与芪竹方诱导MGC-803细胞凋亡机制研究
|
摘要
目的与意义:
胃癌是我国病死率最高的恶性肿瘤之一。临床上外科治疗的患者早期胃癌约有5%,进展期胃癌约有50%,在5年内因复发而死亡,即使作了根治性手术,仍有30%-80%发生局部或远处复发。因此,如何减少或阻止肿瘤复发转移,提高中晚期胃癌患者的临床疗效和远期生存率,是目前最迫切的研究课题。
研究表明:胃癌的发生是一个多阶段、多因素的复杂发展过程。肿瘤的发生和发展不仅与肿瘤细胞的增殖和分化异常有关,而且与细胞凋亡基因和蛋白的变化有关,其调节机制紊乱将导致肿瘤的发生。因此,诱导细胞凋亡的策略成为近年来肿瘤治疗的重点。
中医中药在肿瘤治疗领域的作用越来为人们所重视,为进一步阐明其作用机理,人们从细胞凋亡及其相关蛋白、基因表达的角度进行了大量研究。大量研究表明:中药中的许多成分可阻断肿瘤的发生和发展,具有良好的预防和治疗肿瘤的作用,对胃癌术后复发与转移的治疗有独特的优势。
本研究是针对胃癌术后“正气亏虚,伏邪内蕴”的病机特点,以“益气养阴,解毒化瘀法”为治法而制定的芪竹方,进行了实验和临床两方面研究,验证其治疗胃癌术后的疗效,并系统的从理论和临床两方面阐述其作用机理,为胃癌术后的治疗探索可借鉴的方法和思路,为抗肿瘤术后复发、转移的基础研究提供临床基础。
方法:
1.临床部分:纳入符合胃癌术后诊断标准的35例患者,采用自身前后对照的方法进行治疗,采用QLQ-C30调查表,调查芪竹方治疗患者治疗前后生存质量变化的影响,同时总结导师防治胃癌术后复发与转移的学术思想。
2.实验部分:常规培养人胃癌细胞MGC-803,通过MTT、流式细胞仪、电镜、蛋白印迹等方法,探讨芪竹方对人胃癌细胞MGC-803的增殖与凋亡机制的影响。
结果:
1.芪竹方具有提高胃癌术后患者生存质量的作用,疗前与疗后比较,差异显著(P＜0.05)。
2.芪竹方抑制人胃癌细胞MGC-803的生长、使细胞周期阻止在G_1期,诱导细胞凋亡。
3.芪竹方可改变线粒体跨膜电位ΔΨm,上调cytochrome c蛋白的表达。
结论:
1.芪竹方能够显著改善患者生存质量,是胃癌术后抗复发与转移的有效方剂。
2.芪竹方能够诱导人胃癌细胞MGC-803发生凋亡,其机制与线粒体途径有关。
Objective:Gastric cancer is one of the highest fatality and malignant tumor in China.Clinically, the patients with surgical treatment of about 5%early gastric cancer,about 50%advanced gastric cancer died in 5 years due to relapse,even made a radical operation,there is still 30% -80%of local or distant recurrence.Therefore,it is the most pressing issues to be addressed that how to reduce or prevent tumor recurrence and metastasis,to improve the clinical efficacy and long-term survival in patients with advanced gastric cancer.
Studies show that the incidence of gastric cancer is a multi-stage and multi-factor in the complex process of development.Tumor occurrence and development is not only a process of tumor cell proliferation and differentiation abnormalities,but also a process of anti-apoptosis in the changes in gene and protein,and the adjustment mechanism of the disorder will lead to the occurrence of tumor.Therefore,the induction of apoptosis in cancer becomes an important strategy in recent years.
The role of Chinese medicine in the field of cancer therapy is increasingly important for the people.In order to further elucidate its mechanism,it is of view a great deal of research from the cell apoptosis to its associated protein,gene expression point.Large number of studies showed that many of the components of traditional Chinese medicine may block the tumor occurrence and development of a sound prevention and treatment of tumors,and it has a unique advantage on the effect of postoperative recurrence and metastasis of gastric cancer treatment.
We draft for the rule of Yiqi Yangyin,Jieduhuayu Law and the QiZhu formulae by the characteristics of postoperative gastric cancer research.Therefore,we carried out both experimental and clinical studies to validate its efficacy and mechanism from both theoretical and clinical aspects after the treatment of gastric cancer.We explore the treatment of gastric cancer patients to learn from the methods and ideas for the therapy of tumor recurrence and metastasis.
Methods:
1.Clinical parts:we investigate the influence on the quality of life by the Quality of life questionnaire-Core30 and to sum up mentor Prevention of postoperative recurrence and metastasis of gastric cancer of academic thought.
2.Experimental parts:In order to observe the effects of proliferation and apoptosis on Human Stomach Cancer Cell Line MCG-803 induced by Qi Zhu Formulae,we cultured the cells with routine methods and used the method of Flow cytometry and Western blot.
Results:
1.The quality of survivals could be improved by Qi Zhu Formulae,and there is significant difference(p＜0.05).
2.The growth of Human Stomach Cancer Cell Line MCG-803 could be effectively prohibited by Qi Zhu Formulae,and cell cycle was arrested on G1 phase.
3.The expression of cytochrome c and changes of mitochondrial membrane potential could be induced by Qi Zhu Formula.
Conclusions:
1.The quality of survivals could be improved by Qi Zhu Formula,and it is an effective medicine that could prevent the recurrence of gastric cancer.
2.Mitochondrial pathway plays an important role in the apoptosis on human stomach cancer cell line MCG-803 induced by Qi Zhu Formulae.
胃癌是我国病死率最高的恶性肿瘤之一。临床上外科治疗的患者早期胃癌约有5%,进展期胃癌约有50%,在5年内因复发而死亡,即使作了根治性手术,仍有30%-80%发生局部或远处复发。因此,如何减少或阻止肿瘤复发转移,提高中晚期胃癌患者的临床疗效和远期生存率,是目前最迫切的研究课题。
研究表明:胃癌的发生是一个多阶段、多因素的复杂发展过程。肿瘤的发生和发展不仅与肿瘤细胞的增殖和分化异常有关,而且与细胞凋亡基因和蛋白的变化有关,其调节机制紊乱将导致肿瘤的发生。因此,诱导细胞凋亡的策略成为近年来肿瘤治疗的重点。
中医中药在肿瘤治疗领域的作用越来为人们所重视,为进一步阐明其作用机理,人们从细胞凋亡及其相关蛋白、基因表达的角度进行了大量研究。大量研究表明:中药中的许多成分可阻断肿瘤的发生和发展,具有良好的预防和治疗肿瘤的作用,对胃癌术后复发与转移的治疗有独特的优势。
本研究是针对胃癌术后“正气亏虚,伏邪内蕴”的病机特点,以“益气养阴,解毒化瘀法”为治法而制定的芪竹方,进行了实验和临床两方面研究,验证其治疗胃癌术后的疗效,并系统的从理论和临床两方面阐述其作用机理,为胃癌术后的治疗探索可借鉴的方法和思路,为抗肿瘤术后复发、转移的基础研究提供临床基础。
方法:
1.临床部分:纳入符合胃癌术后诊断标准的35例患者,采用自身前后对照的方法进行治疗,采用QLQ-C30调查表,调查芪竹方治疗患者治疗前后生存质量变化的影响,同时总结导师防治胃癌术后复发与转移的学术思想。
2.实验部分:常规培养人胃癌细胞MGC-803,通过MTT、流式细胞仪、电镜、蛋白印迹等方法,探讨芪竹方对人胃癌细胞MGC-803的增殖与凋亡机制的影响。
结果:
1.芪竹方具有提高胃癌术后患者生存质量的作用,疗前与疗后比较,差异显著(P＜0.05)。
2.芪竹方抑制人胃癌细胞MGC-803的生长、使细胞周期阻止在G_1期,诱导细胞凋亡。
3.芪竹方可改变线粒体跨膜电位ΔΨm,上调cytochrome c蛋白的表达。
结论:
1.芪竹方能够显著改善患者生存质量,是胃癌术后抗复发与转移的有效方剂。
2.芪竹方能够诱导人胃癌细胞MGC-803发生凋亡,其机制与线粒体途径有关。
Objective:Gastric cancer is one of the highest fatality and malignant tumor in China.Clinically, the patients with surgical treatment of about 5%early gastric cancer,about 50%advanced gastric cancer died in 5 years due to relapse,even made a radical operation,there is still 30% -80%of local or distant recurrence.Therefore,it is the most pressing issues to be addressed that how to reduce or prevent tumor recurrence and metastasis,to improve the clinical efficacy and long-term survival in patients with advanced gastric cancer.
Studies show that the incidence of gastric cancer is a multi-stage and multi-factor in the complex process of development.Tumor occurrence and development is not only a process of tumor cell proliferation and differentiation abnormalities,but also a process of anti-apoptosis in the changes in gene and protein,and the adjustment mechanism of the disorder will lead to the occurrence of tumor.Therefore,the induction of apoptosis in cancer becomes an important strategy in recent years.
The role of Chinese medicine in the field of cancer therapy is increasingly important for the people.In order to further elucidate its mechanism,it is of view a great deal of research from the cell apoptosis to its associated protein,gene expression point.Large number of studies showed that many of the components of traditional Chinese medicine may block the tumor occurrence and development of a sound prevention and treatment of tumors,and it has a unique advantage on the effect of postoperative recurrence and metastasis of gastric cancer treatment.
We draft for the rule of Yiqi Yangyin,Jieduhuayu Law and the QiZhu formulae by the characteristics of postoperative gastric cancer research.Therefore,we carried out both experimental and clinical studies to validate its efficacy and mechanism from both theoretical and clinical aspects after the treatment of gastric cancer.We explore the treatment of gastric cancer patients to learn from the methods and ideas for the therapy of tumor recurrence and metastasis.
Methods:
1.Clinical parts:we investigate the influence on the quality of life by the Quality of life questionnaire-Core30 and to sum up mentor Prevention of postoperative recurrence and metastasis of gastric cancer of academic thought.
2.Experimental parts:In order to observe the effects of proliferation and apoptosis on Human Stomach Cancer Cell Line MCG-803 induced by Qi Zhu Formulae,we cultured the cells with routine methods and used the method of Flow cytometry and Western blot.
Results:
1.The quality of survivals could be improved by Qi Zhu Formulae,and there is significant difference(p＜0.05).
2.The growth of Human Stomach Cancer Cell Line MCG-803 could be effectively prohibited by Qi Zhu Formulae,and cell cycle was arrested on G1 phase.
3.The expression of cytochrome c and changes of mitochondrial membrane potential could be induced by Qi Zhu Formula.
Conclusions:
1.The quality of survivals could be improved by Qi Zhu Formula,and it is an effective medicine that could prevent the recurrence of gastric cancer.
2.Mitochondrial pathway plays an important role in the apoptosis on human stomach cancer cell line MCG-803 induced by Qi Zhu Formulae.
引文
[1]徐飚,王建明.胃癌流行病学研究中华肿瘤防治杂志[J].2006,(1):1-4
[2]郭珺,刘琳,王哲海.胃癌肝转移的治疗现状和进展实用癌症杂志[J].2007,(5):32-3
[3]沈克平.有瘤体必虚,有虚首健脾.(邱桂信治疗胃癌的研究思路)[J].医学理论与实践,1999,12(11):625
[4]李和根.刘嘉湘治疗胃癌经验述要[J].辽宁中医杂志.2005,32(7):642
[5]王瑞平,潘宇,叶志超.健脾化瘀合剂配合化疗治疗晚期胃癌18例临床观察[J].江苏中医药2004,25(11):22-23
[6]陆克勤,王利,王蕾.健脾化瘀解毒法治疗中晚期胃癌近期疗效观察[J].中国现代实用医学杂志2004,3(12):71-72
[7]朱国先.癌瘀相关初探[J].浙江中医杂志,2000,35(12):532-534.
[8]陶炼.辨证治疗晚期胃癌40例临床观察[J].湖南中医杂志,2002,(2):5
[9]李满星.辨证治疗胃癌术后34例临床观察[J].湖南中医杂志,1997,13(2):102
[10]周萍,徐国缨,张存钧.张镜人调治胃癌术后的经验[J].辽宁中医杂志,2003,30(9):694-695
[11]周岱翰.临床中医肿瘤学[M].北京:人民卫生出版社,2003.162
[12]刘毅,周洁.中西医结合治疗晚期胃癌30例[J].山东中医杂志,2002,21(3):164-165
[13]王晓.辨证治晚期胃癌40例[J].江西中医药,1999,30(4):28-29
[14]陈郭君.中医辨证分型治疗[J].湖北中医杂志,2000,22(3):19
[15]董安荣,赵建霞,卢金玉.晚期胃癌辨治探析[J].辽宁中医杂志,2000,27(10):443
[16]许玲,孙人志,施俊.中医证型分类的文献研究[J].世界华人消化杂志,2004,12(6):1457-1459
[17]宋家驹.健脾中药抗胃癌术后转移的研究[J].现代中西医结合杂志,2004,13(22):2956-2957
[18]周荣耀,吴丽英,倪爱娣,等.抗炎1号静脉注射液治疗24例中晚期胃癌的临床观察[J].上海中医药杂志,2000,34(8):15-16
[19]郑爱华,郭娜,李国良.殛癌隳瘤散治疗胃癌48例临床观察[J].辽宁中医学院学报,2001,3(2):119-120
[20]陈会林,李建胜,陆文彬.抗粘连汤在胃癌术后的应用[J].福建中医药,2003,34(6):30
[21]刘静.健脾中药治疗胃癌术后患者的临床观察[J].湖北中医杂志,2003,25(7):8-9
[22]顾兆雄.六君薏苡三虫汤治疗晚期胃癌术后30例[J].浙江中医杂志,1990,(10):433
[23]俞勇,张立立,蔡乾荣,等.半夏泻心汤加味治疗胃癌术后化疗消化道反应疗效观察[J].浙江中医药大学学报,2006,30(4):401-402
[24]郑坚,顾缨,周浩,等.健脾中药对进展期胃癌生存期及转移复发状况的作用[J].辽宁中医杂志,2003,30(8):683-684
[25]杨金坤,郑坚,沈克平,等.中药胃肠安防治进展期胃癌术后转移的临床研究[J].中国中西医结合杂志,2003,23(8):580-552
[26]许尤琪,薛惠宁,诸晓秋,等.健脾活血解毒中药抗胃癌术后转移的临床观察[J].中西医结合学报,2003,1(3):192-194
[27]王志学,焦中华,消瘤平移合剂抗肿瘤术后转移的临床及实验研究[J].山东中医药大学学 报,1999,23(4):213-216
[28]赵健雄,沈世林,曲勇,等.扶正抑瘤颗粒对食管癌胃癌术后患者免疫功能及血液流变学影响的临床观察[J].中华实用中西医杂志,2003,16(4):517-518
[29]卜平,周荣卿,陈齐鸣.扶正化瘀方对胃癌患者术后转移的抑制作用及T淋巴细胞亚群的影响[J].中医杂志,2001,42(4):226-227
[30]杨继泉,张斌斌.中医药治疗中晚期胃癌102例临床疗效分析[J].中医杂志,2000,41(8):483-484
[31]李财宝,航军,冯寿全.149例胃癌术后化疗与中药综合治疗临床观察[J].上海中医药杂志,2002,36(2):15-16
[32]杨华,史国军.胃癌术后中西医结合治疗临床观察30例.中医药管理杂志[J].2007,15(6):454-456
[33]许运明,吴明生,王自安,等.扶正消瘤液增强LAK抗肿瘤活性的实验研究[J].辽宁中医志,1998,25(4):188.
[34]邓卫平,官成浓.榄香烯乳联合化疗对进展期胃癌老年患者细胞免疫功能的影响[J].广东医学院学报,2001,19(5):350
[35]彭轶霞,张亚密,陈明霞.清瘀扶正汤对中晚期胃癌患者免疫功能的影响[J].辽宁中医杂志,2006,11(33):1459
[36]徐光炜.胃癌治疗的现状及问题[J].外科理论与实践,2003,8(1):3
[37]闵存云,李庆明,刘和强.健脾导滞方对人胃癌细胞的作用[J].中药材,2004,27(12):935
[38]李晓光,谢锦玉,李文梅,等.大蒜油诱导人胃癌细胞分化和凋亡的机制研究[J].中华肿瘤杂志,1998,20(5):325
[39]李宝元,梁云燕,王代树.中药白龙片与HMBA对有胃癌不同周期细胞癌基因与抑癌基因表达调控的共性研究[J].中国中西医结合杂志,2001,21(4):287
[40]孙珏,沈建华,朱美华,等.消癌平对人胃癌细胞治疗作用的实验研究[J].上海中医药大学学报,2000,14(2):41
[41]李军祥,王志斌,朱陵群,等.三七提取物对经MNNG转化后的GES21细胞增殖抑制及促凋亡作用[J].中国中西医结合杂志,2005,25(8):719
[42]左小东,崔永安.华蟾素对MGC-803细胞生长及凋亡影响的实验研究[J].临床肿瘤学杂志,2003,8(1):34
[43]陈华,杨守峰.癌平口服液含药血清对人胃癌细胞凋亡的影响[J].中国中医药信息杂志,2002,9(8):20
[44]涂水平,江石湖,谭继宏,等.羟基喜树碱诱导胃癌细胞凋亡的作用机制初步研究[J].中华消化杂志,2001,21(5):274.
[45]叶建明,胡品津,等缬草波春诱导对MKN-45胃癌细胞凋亡的影响[J].世界华人消化志,2007,15(1):22-28
[46]王兵,王杰军.人参皂苷Rg3对胃癌诱导血管内皮细胞增殖的抑制作用[J].肿瘤防治志,2001,8(3):2347
[47]苏晓妹,李峻,许玲等.消痰散结方对鸡胚绒毛尿囊膜血管生成及胃癌组织中VEGF表达的影响[J].山东中医药大学学报,2003,27(4):296
[48]徐晓峰,王海波,等.蔡氏扶正消症汤对胃癌血管生成影响的实验研究[J].浙江中医志,2007,3(42):171-172
[49]徐力,王明艳,许冬青等.三物白散加味方影响胃癌相关基因表达的实验研究.南京中医药大学学报(自 然科学版),2002,18(3):158
[50]余谦,李庆明,吴伟康,等.中药胃康宁对实验性胃癌PCNA、p53蛋白表达的干预作用[J].中山医科大学学报.2000.21(4):38-42
[51]何玉军,苏安英,柴锡庆,等.中药复方软坚消肿液抗肿瘤作用及机理[J].1998,1(1):14
[52]范钰,林庚金,钱立平,等.榄香烯乳对大鼠胃粘膜癌变c-myc基因表达及端粒酶活性的影响.中国肿瘤临床,2002,29(3):211
[53]赵爱光,杨金坤,尤圣富,等中药胃肠安诱导裸鼠胃癌转移瘤细胞凋亡的途径及基因调控的研究[J].中西医结合学报,2007,5(5):287-297
[54]李勇,刘冀红,赵群,等.大蒜素对人胃腺癌BGC-823细胞影响的研究[J].中国中西医结合外科志,2001,7(5):307
[55]谷善青,梁云燕,樊立人,等.复方白龙片对人胃癌细胞两条信号通路的调控[J].中国中西医结合杂志,1997,17(7):404
[56]罗海滨,漆伟.大葱油对体外培养的胃癌细胞SGC-803的影响[J].第四军医大学学报,2007,28(19):1771-1774
[57]朱国福,钱力兰,陈伟,等.钱氏消瘤口服液对胃癌细胞分化影响的研究[J].湖南中医杂志,2002,18(4):56
[58]陈峻青.胃癌根治术后复发形式和方法的选择[J].中国实用外科杂志,1995,15(12):709
[59]Yoo CH,Noh SH,Shin DW,et al.Recurrence following curative resection for gastric carcinoma[J].Br J Surg,2002;87(2):236
[60]金桂龙,丁之玮,贾菊萍.胃癌术后复发转移的超声检查[J].中国肿瘤临床与康复,2005,12(6):532-534
[61]黄涛,任权,玛迎春,等.胃大部切除术后残胃病变的内镜分析.中国内镜杂志,2004,10(1):90-91
[62]Ingram M,Arregui ME.Endoscopic ultrasonography[J].Surg Clin North Am,2004,84(4):1035-1059.
[63]UkrisnaaP,Wang win yu virat M.Evaluation of the sensitivity of the double-contrast Upper gastrointestinal series in the diangosis of gasrtic.eaneer.J Med Assoc Thai,2004,87(1):80-86
[64]谢德宁,商秀林.胃癌浸润转移的螺旋CT诊断[J].中国误诊学杂志,2006,6(6):1063-1064
[65]王志军,包小娜,刘杰,等.胃癌术后复发的MRI研究[J].临床放射学杂志,2007,26(12):1294-1297
[66]MaccioniF.Currentstauts of gastrointestinal MRI.Abdom Imaging,2002,27(4):358-360
[67 周渠新,徐伟栋,陈艳.联合检测CA72-4、CEA、CA19-9对胃癌术后复发的监测价值[J].浙江创伤外科,2008,13(4):362-363
[68]Ghossein RA,Scher HI,Gerald WL,et al.Detection of circulating tumor cells in patients with localized and metastatic prostatic carcino-ma:clinical implications[J].Clin Oncol,1995,13(5):1195-1200
[69]杨万勇,杜宗孝,蔡永梅,等.胃癌患者外周血癌细胞CEAmRNA表达与胃癌微转移关系的研究[J].宁夏医学杂志,2001,23(5):262-264.
[70]Mori M,Mimori K,Ueo H,et al.Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood byreverse transcription-polymerase chain reaction in patients with gas-trointestinal or breast carcinomas.J Clin Oncol,1998,16(1):128-132.
[71]温玉刚,潘常青,李克.磁激活细胞分离术检测胃癌循环血微转移的研究[J].中国现代普通外科进 展,2006,9(2):102-104.
[72]XuW,ZhangMW,HuangJ,et al.Correlation between CK18 gene and gastric carcinom a micrometastasis[J].World J Gastroen tero,2005,11(41):6530-6534.
[73]Kubota K,NakanishiH,Hiki N,et a.l Quantitative detection of micrometastases in the lymph nodes gastric cancer patients with real-time RT-PCR:a comparative study with immunohisto chemis-try[J].Int JCancer,2003,105(1):136-143.
[74]Oki E,MaecharaY,Tokunaga E,etal.Detection of disseminatde cancer cell sinbone marrow of Gastric cancer using real time quantitative reverse transcrptase Polymerase chaine recation.Cnacer Lett,2002,188(1-2):191-198
[75]Wang Z,Zhang X,Xu H,etal.Detection of peritoneal micrometastasis by reverse transcriptase-Polylmerase Chain reaction of heparanase mRNA and cytology in Peritoneal wash smaples.J Surg Oncol,2005,90(2):59-65
[76]VogelP,Rusehoff J,KummelS,etal.Pron gastic value of microscpoic Peritoneal dissemination:comparision between colon and gasrtic cancer.DisColon Rectum,2000,43(1):92-100
[77]Marutsuka T,Shimada S,Shiomori K,et al.Mechanisms of peritoneal metastasis after operation for non-serosa invasive gastric carcinoma[J].Clin CancerRes,2003;9:678-85.
[78]To Em,ChanWY,Chow C,etal.Gastric cancer cell detection in perito-neal washing:cytology versus RT-PCR for CEA transcripts[J]DiagnMolPatho,2003;12:88-95.
[79]下舒宝.复发胃癌及晚期胃癌的外科治疗.中国实用外科杂志 2000,20(10):587-588
[80]ToPuz E,Basaran M,SaiP P,et al.Adjuvant intraperitoneal chemotheerapy with cisplatinum,mitoxnatrone,5-fluorouracil,and calcium in Patients with gastric canceer:a pasellstudy.Am J Clin Oncol.2002,25(6):619-624
[81]徐光炜.胃癌治疗的现状及问题.外科理论与实践 2003,8(1):3-6
[82]Lin L,Ye Z,Xue E.Intraopertaive ultrasono graphic detection of liver metastastis from tumors of ingestive tract.ZhonghuaZhongliu zazhi,2001,23(3):234-236
[83]Kawaskai H,Shibata S,Suzuki H,et al.Hepatic recetions for synchronous liver metastases of gastric cancer.Gan To Kaga ku Ryoho,2001,28(11):1740-1742
[27]李槐.肝转移瘤经肝动脉介入治疗疗效评价及影响因素分析[M].中国临床肿瘤学教育专辑,2005:155.
[84]高永辉,周旋,杨冬.胃癌卵巢转移55例分析.中国误诊学杂志,2006,6(5):951
[85]金愚林.胃癌内科化学治疗的新进展.医学临床研究,2003,20(10):735-738v86]Webb A,Cunningham D,Scarfef JH,etal.Randomized trial comparing epirubicin cisplatin and fluorouracil versus fluorouracil,doxorubicin and mehtotrexaet in advanced ecophago gastric cancer J Clin Oncol,2005,15(6):261-267
[87]Bugat R.Irinoectcan in the treatment of gastric cancer.Ann Onoc 2003,14(2):1137-1140
[88]JinML,Chnen Q,Chen FQ,et al.Oxaliplatin in combination with LV5-FU2 in Chinese patients with advanced gastric cancer.Proe Am Soc Clin Oncol,2002,31:558
[89]Tbebntt N,Nonman A,Cunnnigham D,et al.Randomside,multicenter phaseⅢsutdy comparing with capecitabine fluorouracil and oxaliplatin with cisplatin inpatinets with advanced oescphago gastric cancer,interim analysis.Proc Am Soc Clin Oncol,2002,21:523.
[90]李玉升.晚期胃癌的化疗与用药.中华医学杂志 2004,84(24):2139-2141
[91]刘鹏,邓清华.胃癌放射治疗的进展.国外医学肿瘤学分册,2005,32(7):552-554
[92]Kim JP Yu HJ Lee JH.Results of immunochemo-surgery for gastric carcinoma.Hepato gastroenterology,2001,48(41):1227-1230
[93]汪灏,余佩武,赵永亮,等.自体树突状细胞疫苗诱导胃癌患者术后肿瘤特异性免疫反应的作用[J].第三军医大学学报,2006,28(5):408-410.
[94]Homma S,KikuchiT,IshijiN,et a.l Cancer immunotherapy by fusions of dendritic and tumour cells and rhIL-12[J].Eur JClin Invest,2005,35(4):279-286.
[95]王冠庭.晚期胃癌中西医结合治疗的思睡与体会[J].中医杂志,2001,42(9):560.
[96]黄天风.黄芪的抗肿瘤作用及其免疫学机制的实验研究[J].中华临床医学研究杂志,2007,13(4):431-432
[97]陈永仲,郭仁强.黄芪皂贰甲对小鼠腹腔巨噬细胞的影响.中国药理学与毒理学杂志,1998,2(4):11
[98]宁康健,阮样春,吕锦芳.黄芪对小鼠腹腔巨噬细胞吞噬能力的影响[J].中国中药杂志,2005,30(21):1670-167
[99]江德清,沈文梅,田亚平等.黄芪总黄酮对犬模拟肺癌术中放疗抗辐射损伤作用研究.中华放射医学与防护杂志,1996,16(6):399
[100]董晓辉,董竟成.黄芪注射液增强树突细胞的抗肺癌作用[J].中国实验方剂学杂志,2005,11(1):25-28.
[101]郑虎占,董涌起宏,佘靖等.中药现代研究与应用.第4卷.学苑出版社
[102]单颖,姜东,潘兴瑜等.玉竹多糖对衰老模型鼠免疫功能的影响.中国老年学杂志,2007,1(27):20-21
[103]李尘远,潘兴瑜,刘辉.玉竹提取物B抗肿瘤机制的初步研究.中国免疫学杂志.2003,19(4):253-254
[104]林志彬.灵芝抗肿瘤活性和免疫调节作用的研究进展.北京大学学报,2002,34,(5):493-497
[105]张闯,李长国,张旗军.薏苡仁酯对荷瘤小鼠Na~+/K~+-ATPase活性的影响[J].黑龙江中医药,2000,13(2):89.
[106]杨骅,王仙平,郁琳琳等.榄香烯抗癌作用与诱发肿瘤细胞凋亡[J].中华肿瘤杂志 1996,18(3):169
[107]李应东,李啸红,魏道武,等.莪术对硫酸镍诱发大鼠鼻咽癌前病变的影响[J].癌症.1995,14(6):460
[108]高凯民,周玲,陈金英,等.仙鹤草煎剂对HL-60 细胞的体外诱导凋亡作用[J].中药材,2000,23(9):561-562.
[109]袁静,王元勋,侯正明,等.仙鹤草鞣酸体外对人体肿瘤细胞的抑制作用[J].中国中医药科技,2000,7(6):378-379.
[110]吴琳华,郭劲柏,刘红梅,等.仙鹤草注射液对人癌细胞生长抑制作用的研究[J].中国中医药科技,2005,12(5):297-298.
[111]丁维俊,张天娥,王宇,等.仙鹤草抗癌活性成分及机理探讨[J].辽宁中医杂志,2006,33(22):251-252.
[112]李宝文,刘丽梅,王丽杰.仙鹤草对小鼠体液免疫的研究[J].辽宁药物与临床,2002,5(6):15-16
[113]曹勇,骆永珍.仙鹤草对荷瘤小鼠IL-2活性影响的研究[J].中国中医药科技,1999,(4):24
[114]金在久.仙鹤草的化学成分及临床研究进展[J].华西药学杂志,2006,21(5):469
[115]陈凌云,杨国祥.半夏药理研究概况[J].云南中医学院学报,1997,20(4):17-19.
[116]周金黄.中药药理学[M].上海:上海科技出版社.1986:125-126
[117]单保恩,张金艳,杜肖娜,等.白花蛇舌草的免疫学活性和抗肿瘤活性[J].中国中西医结合杂志,2001,21(5):370-374.
[118]李瑞,张金艳,杜肖娜,等.白花蛇舌草水溶性提取物的抗肿瘤作用和对化疗损伤的保护作用的研究[J].中国药学,2002,11(2):58
[119]雅达斌,李少钦.白花蛇舌草激活肿瘤细胞产生超氧化物和激活半胱氨酸天冬氨酸蛋白酶诱导肿瘤细胞凋亡[J].中西医结合学报,2006,4(5):485-489
[120]UICC,胃癌TNM分期[M].1997,第5版
[121]Gotay CL,Korn EL,Mary S,et al.癌症治疗方案中的生活质量评价方案发展的研究论题.国外医学肿瘤分册,1993,20(2):107
[122]洪明晃主编.科研设计测量评价.广州:中山大学出版社,1994:76
[123]万崇华,罗家洪.癌症患者生命质量测定与应用[M].第一版.北京:科学技术出版社,2007
[124]董宣,李天霖,王滨燕,等.生活质量评价-一种多维的健康评价方法.国外医学社会医学分册,1996,13(3):118
[125]Hussein MR,Haeme AK,Wood GS.Apoptosis and melanoma:molecular mechanisms.J Phathol,2003,199(3):275-288.
[126]王晓华.芪竹方诱导人胃癌细胞MGC-803凋亡和影响端粒酶及其hTERT基因蛋白表达的研究[D]2006.
[127]司徒镇强,吴军正主编.细胞培养.西安.世界图书出版公司,1996.
[128]Spugnini EP,Campioni M,DAvino A,et al.Cell-cycle molecules in meso the lioma:an overview.J Exp Clin Cancer Res.2007;26(4):443-449.
[129]Collins K,JacksT,Paveltich NP.The cell cycle and cancer.Proc Nail Acad Sci USA.1997;94:2776-2778.
[130]Malumbres M.Cyclins and related kinases in cancer cells.J BUON.2007,12(1):S45-S52.
[131]Lemos PA,Serruys PW,van Domburg RT,et al.Post-sirolimus-elutingstent restession treated with repeat percutaneous intervention:late anglo-graphic and clinical outcomes[J]Circulation,2004,109(21):2500-2.
[132]Sengupta A,Ghosh S,Bhattacharjee S.Allium vegetables in cancer prevention an overview.Asian Pac J Cancer Prey 2004;5:237-245
[133]沈冰冰,高善玲.细胞凋亡与胃癌哈尔滨医科大学学报[J].2001,35(1):75-77.
[134]]Kerr JF,Wyllie AH,Currie AR.Apoptosis:a basic biological phenomenon with wide-ranging implications in tissue kinetics.British Journal of Cancer,1972,26(4):239-257
[135].Green DR,Apoptotic pathways:the roads to ruin.Cell,1998,94(6):695.
[136]赵文丽.细胞凋亡及其检测技术的进展.山西职工医学院学报[J].2004.14(2):68-69
[137]阮红梅,张奇亚.流式细胞术在细胞凋亡研究中的应.动物医学进展[J],2005,26(3):12-15
[138]Green DR,Reed JC.Mitochondria and apoptosis Science[J].Seience,1998,281(5381):1309-1302.
[139].Bruno Antonsson. Mitochondria and the bcl-2 family Proteins in apoptosis signaling Pathways, Molecular and Cellular Biochemistry,2004;256/257:141-155,
[140]Hai N Jr. Mitochondria: A novel target for the chemo Prevention of cancer [J].Apoptosis, 2005, 10(4): 687-705
[141]Wang XD. The expanding role of mitochondria in apoptosis [J]. Genes Dev, 2001,15(11): 2922-2933.
[142]Gottlieb RA.Mitochondria:execution central[J]. FEBS Lett,2000;482:6-12
[143]Green DR,Reed Jc.Mitochondria and apoptosis [J].Science,1998,281(5381):1309-1312
[144]Fall C,Bennetl JJ. Visualization of cyclosporion A and ca2+-sensitive cycli calmito chondrial depolarization in cell culture [J] Biochim, BioPhys Acta, 1999,1410(1): 772-784.
[145]Li K,Li Y,Shelton J M, et al. Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis[J].Cell,2000,101(4):389-399.
[146]Acehan D, Jiang X, Morgan DG,et al. Three-dimensional structure of the apoptosome:implications for assembly,procaspase-9 binding and activation[J].Mol Cell,2002,9(2):423-432.
[147]Jiang X, Wang X. Cytochrome c promotescaspase-9 activation by inducing nucleotide binding to Apaf-1[J].J BiolChem, 2000, 275(40): 31199-31203.
[148]Barros M H, Netto E S, Kowuhowski A.H2O2 generation in saccharomy cescevevisiac respirtory pet mutans: effect ofcytochrome c [J]. Biol Med, 2003,35(2): 179-188.
[149]Shih C M, Ko W C, Wu J S, et al. Mediating of caspase-independent apoptosis by cadmium through the mitochondria-ROS pathway in MRC-5fibroblasts[J].Cell Biochem, 2004, 91(2): 384-397.
[150]Ricci J E, Munoz-Pinedo C, Fitzgerald P, et al. Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain[J].Cell,2004,117(6):773-786.
[151]Saito M, Korsmeyer SJ, Schlesinger PH.BAX-dependent transport of cytochrome c reconstituted in pure liposomes [J]. Nat Cell Biol, 2000, 2(8):553-555.
[152]Leu J I, Dumont P, Hafey M, et al. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcll complex[J].Nat Cell Biol,2004,6(5):443-450.
[153]Cheng E H, Wei M C, Weiler S, et al.BCL-2, BCL-X(L)sequester BH3 domain-only molecules preventing BAX-and BAK-mediated mitochondrial apoptosis[J].Mol Cell,2001,8(3):705-711.
[2]郭珺,刘琳,王哲海.胃癌肝转移的治疗现状和进展实用癌症杂志[J].2007,(5):32-3
[3]沈克平.有瘤体必虚,有虚首健脾.(邱桂信治疗胃癌的研究思路)[J].医学理论与实践,1999,12(11):625
[4]李和根.刘嘉湘治疗胃癌经验述要[J].辽宁中医杂志.2005,32(7):642
[5]王瑞平,潘宇,叶志超.健脾化瘀合剂配合化疗治疗晚期胃癌18例临床观察[J].江苏中医药2004,25(11):22-23
[6]陆克勤,王利,王蕾.健脾化瘀解毒法治疗中晚期胃癌近期疗效观察[J].中国现代实用医学杂志2004,3(12):71-72
[7]朱国先.癌瘀相关初探[J].浙江中医杂志,2000,35(12):532-534.
[8]陶炼.辨证治疗晚期胃癌40例临床观察[J].湖南中医杂志,2002,(2):5
[9]李满星.辨证治疗胃癌术后34例临床观察[J].湖南中医杂志,1997,13(2):102
[10]周萍,徐国缨,张存钧.张镜人调治胃癌术后的经验[J].辽宁中医杂志,2003,30(9):694-695
[11]周岱翰.临床中医肿瘤学[M].北京:人民卫生出版社,2003.162
[12]刘毅,周洁.中西医结合治疗晚期胃癌30例[J].山东中医杂志,2002,21(3):164-165
[13]王晓.辨证治晚期胃癌40例[J].江西中医药,1999,30(4):28-29
[14]陈郭君.中医辨证分型治疗[J].湖北中医杂志,2000,22(3):19
[15]董安荣,赵建霞,卢金玉.晚期胃癌辨治探析[J].辽宁中医杂志,2000,27(10):443
[16]许玲,孙人志,施俊.中医证型分类的文献研究[J].世界华人消化杂志,2004,12(6):1457-1459
[17]宋家驹.健脾中药抗胃癌术后转移的研究[J].现代中西医结合杂志,2004,13(22):2956-2957
[18]周荣耀,吴丽英,倪爱娣,等.抗炎1号静脉注射液治疗24例中晚期胃癌的临床观察[J].上海中医药杂志,2000,34(8):15-16
[19]郑爱华,郭娜,李国良.殛癌隳瘤散治疗胃癌48例临床观察[J].辽宁中医学院学报,2001,3(2):119-120
[20]陈会林,李建胜,陆文彬.抗粘连汤在胃癌术后的应用[J].福建中医药,2003,34(6):30
[21]刘静.健脾中药治疗胃癌术后患者的临床观察[J].湖北中医杂志,2003,25(7):8-9
[22]顾兆雄.六君薏苡三虫汤治疗晚期胃癌术后30例[J].浙江中医杂志,1990,(10):433
[23]俞勇,张立立,蔡乾荣,等.半夏泻心汤加味治疗胃癌术后化疗消化道反应疗效观察[J].浙江中医药大学学报,2006,30(4):401-402
[24]郑坚,顾缨,周浩,等.健脾中药对进展期胃癌生存期及转移复发状况的作用[J].辽宁中医杂志,2003,30(8):683-684
[25]杨金坤,郑坚,沈克平,等.中药胃肠安防治进展期胃癌术后转移的临床研究[J].中国中西医结合杂志,2003,23(8):580-552
[26]许尤琪,薛惠宁,诸晓秋,等.健脾活血解毒中药抗胃癌术后转移的临床观察[J].中西医结合学报,2003,1(3):192-194
[27]王志学,焦中华,消瘤平移合剂抗肿瘤术后转移的临床及实验研究[J].山东中医药大学学 报,1999,23(4):213-216
[28]赵健雄,沈世林,曲勇,等.扶正抑瘤颗粒对食管癌胃癌术后患者免疫功能及血液流变学影响的临床观察[J].中华实用中西医杂志,2003,16(4):517-518
[29]卜平,周荣卿,陈齐鸣.扶正化瘀方对胃癌患者术后转移的抑制作用及T淋巴细胞亚群的影响[J].中医杂志,2001,42(4):226-227
[30]杨继泉,张斌斌.中医药治疗中晚期胃癌102例临床疗效分析[J].中医杂志,2000,41(8):483-484
[31]李财宝,航军,冯寿全.149例胃癌术后化疗与中药综合治疗临床观察[J].上海中医药杂志,2002,36(2):15-16
[32]杨华,史国军.胃癌术后中西医结合治疗临床观察30例.中医药管理杂志[J].2007,15(6):454-456
[33]许运明,吴明生,王自安,等.扶正消瘤液增强LAK抗肿瘤活性的实验研究[J].辽宁中医志,1998,25(4):188.
[34]邓卫平,官成浓.榄香烯乳联合化疗对进展期胃癌老年患者细胞免疫功能的影响[J].广东医学院学报,2001,19(5):350
[35]彭轶霞,张亚密,陈明霞.清瘀扶正汤对中晚期胃癌患者免疫功能的影响[J].辽宁中医杂志,2006,11(33):1459
[36]徐光炜.胃癌治疗的现状及问题[J].外科理论与实践,2003,8(1):3
[37]闵存云,李庆明,刘和强.健脾导滞方对人胃癌细胞的作用[J].中药材,2004,27(12):935
[38]李晓光,谢锦玉,李文梅,等.大蒜油诱导人胃癌细胞分化和凋亡的机制研究[J].中华肿瘤杂志,1998,20(5):325
[39]李宝元,梁云燕,王代树.中药白龙片与HMBA对有胃癌不同周期细胞癌基因与抑癌基因表达调控的共性研究[J].中国中西医结合杂志,2001,21(4):287
[40]孙珏,沈建华,朱美华,等.消癌平对人胃癌细胞治疗作用的实验研究[J].上海中医药大学学报,2000,14(2):41
[41]李军祥,王志斌,朱陵群,等.三七提取物对经MNNG转化后的GES21细胞增殖抑制及促凋亡作用[J].中国中西医结合杂志,2005,25(8):719
[42]左小东,崔永安.华蟾素对MGC-803细胞生长及凋亡影响的实验研究[J].临床肿瘤学杂志,2003,8(1):34
[43]陈华,杨守峰.癌平口服液含药血清对人胃癌细胞凋亡的影响[J].中国中医药信息杂志,2002,9(8):20
[44]涂水平,江石湖,谭继宏,等.羟基喜树碱诱导胃癌细胞凋亡的作用机制初步研究[J].中华消化杂志,2001,21(5):274.
[45]叶建明,胡品津,等缬草波春诱导对MKN-45胃癌细胞凋亡的影响[J].世界华人消化志,2007,15(1):22-28
[46]王兵,王杰军.人参皂苷Rg3对胃癌诱导血管内皮细胞增殖的抑制作用[J].肿瘤防治志,2001,8(3):2347
[47]苏晓妹,李峻,许玲等.消痰散结方对鸡胚绒毛尿囊膜血管生成及胃癌组织中VEGF表达的影响[J].山东中医药大学学报,2003,27(4):296
[48]徐晓峰,王海波,等.蔡氏扶正消症汤对胃癌血管生成影响的实验研究[J].浙江中医志,2007,3(42):171-172
[49]徐力,王明艳,许冬青等.三物白散加味方影响胃癌相关基因表达的实验研究.南京中医药大学学报(自 然科学版),2002,18(3):158
[50]余谦,李庆明,吴伟康,等.中药胃康宁对实验性胃癌PCNA、p53蛋白表达的干预作用[J].中山医科大学学报.2000.21(4):38-42
[51]何玉军,苏安英,柴锡庆,等.中药复方软坚消肿液抗肿瘤作用及机理[J].1998,1(1):14
[52]范钰,林庚金,钱立平,等.榄香烯乳对大鼠胃粘膜癌变c-myc基因表达及端粒酶活性的影响.中国肿瘤临床,2002,29(3):211
[53]赵爱光,杨金坤,尤圣富,等中药胃肠安诱导裸鼠胃癌转移瘤细胞凋亡的途径及基因调控的研究[J].中西医结合学报,2007,5(5):287-297
[54]李勇,刘冀红,赵群,等.大蒜素对人胃腺癌BGC-823细胞影响的研究[J].中国中西医结合外科志,2001,7(5):307
[55]谷善青,梁云燕,樊立人,等.复方白龙片对人胃癌细胞两条信号通路的调控[J].中国中西医结合杂志,1997,17(7):404
[56]罗海滨,漆伟.大葱油对体外培养的胃癌细胞SGC-803的影响[J].第四军医大学学报,2007,28(19):1771-1774
[57]朱国福,钱力兰,陈伟,等.钱氏消瘤口服液对胃癌细胞分化影响的研究[J].湖南中医杂志,2002,18(4):56
[58]陈峻青.胃癌根治术后复发形式和方法的选择[J].中国实用外科杂志,1995,15(12):709
[59]Yoo CH,Noh SH,Shin DW,et al.Recurrence following curative resection for gastric carcinoma[J].Br J Surg,2002;87(2):236
[60]金桂龙,丁之玮,贾菊萍.胃癌术后复发转移的超声检查[J].中国肿瘤临床与康复,2005,12(6):532-534
[61]黄涛,任权,玛迎春,等.胃大部切除术后残胃病变的内镜分析.中国内镜杂志,2004,10(1):90-91
[62]Ingram M,Arregui ME.Endoscopic ultrasonography[J].Surg Clin North Am,2004,84(4):1035-1059.
[63]UkrisnaaP,Wang win yu virat M.Evaluation of the sensitivity of the double-contrast Upper gastrointestinal series in the diangosis of gasrtic.eaneer.J Med Assoc Thai,2004,87(1):80-86
[64]谢德宁,商秀林.胃癌浸润转移的螺旋CT诊断[J].中国误诊学杂志,2006,6(6):1063-1064
[65]王志军,包小娜,刘杰,等.胃癌术后复发的MRI研究[J].临床放射学杂志,2007,26(12):1294-1297
[66]MaccioniF.Currentstauts of gastrointestinal MRI.Abdom Imaging,2002,27(4):358-360
[67 周渠新,徐伟栋,陈艳.联合检测CA72-4、CEA、CA19-9对胃癌术后复发的监测价值[J].浙江创伤外科,2008,13(4):362-363
[68]Ghossein RA,Scher HI,Gerald WL,et al.Detection of circulating tumor cells in patients with localized and metastatic prostatic carcino-ma:clinical implications[J].Clin Oncol,1995,13(5):1195-1200
[69]杨万勇,杜宗孝,蔡永梅,等.胃癌患者外周血癌细胞CEAmRNA表达与胃癌微转移关系的研究[J].宁夏医学杂志,2001,23(5):262-264.
[70]Mori M,Mimori K,Ueo H,et al.Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood byreverse transcription-polymerase chain reaction in patients with gas-trointestinal or breast carcinomas.J Clin Oncol,1998,16(1):128-132.
[71]温玉刚,潘常青,李克.磁激活细胞分离术检测胃癌循环血微转移的研究[J].中国现代普通外科进 展,2006,9(2):102-104.
[72]XuW,ZhangMW,HuangJ,et al.Correlation between CK18 gene and gastric carcinom a micrometastasis[J].World J Gastroen tero,2005,11(41):6530-6534.
[73]Kubota K,NakanishiH,Hiki N,et a.l Quantitative detection of micrometastases in the lymph nodes gastric cancer patients with real-time RT-PCR:a comparative study with immunohisto chemis-try[J].Int JCancer,2003,105(1):136-143.
[74]Oki E,MaecharaY,Tokunaga E,etal.Detection of disseminatde cancer cell sinbone marrow of Gastric cancer using real time quantitative reverse transcrptase Polymerase chaine recation.Cnacer Lett,2002,188(1-2):191-198
[75]Wang Z,Zhang X,Xu H,etal.Detection of peritoneal micrometastasis by reverse transcriptase-Polylmerase Chain reaction of heparanase mRNA and cytology in Peritoneal wash smaples.J Surg Oncol,2005,90(2):59-65
[76]VogelP,Rusehoff J,KummelS,etal.Pron gastic value of microscpoic Peritoneal dissemination:comparision between colon and gasrtic cancer.DisColon Rectum,2000,43(1):92-100
[77]Marutsuka T,Shimada S,Shiomori K,et al.Mechanisms of peritoneal metastasis after operation for non-serosa invasive gastric carcinoma[J].Clin CancerRes,2003;9:678-85.
[78]To Em,ChanWY,Chow C,etal.Gastric cancer cell detection in perito-neal washing:cytology versus RT-PCR for CEA transcripts[J]DiagnMolPatho,2003;12:88-95.
[79]下舒宝.复发胃癌及晚期胃癌的外科治疗.中国实用外科杂志 2000,20(10):587-588
[80]ToPuz E,Basaran M,SaiP P,et al.Adjuvant intraperitoneal chemotheerapy with cisplatinum,mitoxnatrone,5-fluorouracil,and calcium in Patients with gastric canceer:a pasellstudy.Am J Clin Oncol.2002,25(6):619-624
[81]徐光炜.胃癌治疗的现状及问题.外科理论与实践 2003,8(1):3-6
[82]Lin L,Ye Z,Xue E.Intraopertaive ultrasono graphic detection of liver metastastis from tumors of ingestive tract.ZhonghuaZhongliu zazhi,2001,23(3):234-236
[83]Kawaskai H,Shibata S,Suzuki H,et al.Hepatic recetions for synchronous liver metastases of gastric cancer.Gan To Kaga ku Ryoho,2001,28(11):1740-1742
[27]李槐.肝转移瘤经肝动脉介入治疗疗效评价及影响因素分析[M].中国临床肿瘤学教育专辑,2005:155.
[84]高永辉,周旋,杨冬.胃癌卵巢转移55例分析.中国误诊学杂志,2006,6(5):951
[85]金愚林.胃癌内科化学治疗的新进展.医学临床研究,2003,20(10):735-738v86]Webb A,Cunningham D,Scarfef JH,etal.Randomized trial comparing epirubicin cisplatin and fluorouracil versus fluorouracil,doxorubicin and mehtotrexaet in advanced ecophago gastric cancer J Clin Oncol,2005,15(6):261-267
[87]Bugat R.Irinoectcan in the treatment of gastric cancer.Ann Onoc 2003,14(2):1137-1140
[88]JinML,Chnen Q,Chen FQ,et al.Oxaliplatin in combination with LV5-FU2 in Chinese patients with advanced gastric cancer.Proe Am Soc Clin Oncol,2002,31:558
[89]Tbebntt N,Nonman A,Cunnnigham D,et al.Randomside,multicenter phaseⅢsutdy comparing with capecitabine fluorouracil and oxaliplatin with cisplatin inpatinets with advanced oescphago gastric cancer,interim analysis.Proc Am Soc Clin Oncol,2002,21:523.
[90]李玉升.晚期胃癌的化疗与用药.中华医学杂志 2004,84(24):2139-2141
[91]刘鹏,邓清华.胃癌放射治疗的进展.国外医学肿瘤学分册,2005,32(7):552-554
[92]Kim JP Yu HJ Lee JH.Results of immunochemo-surgery for gastric carcinoma.Hepato gastroenterology,2001,48(41):1227-1230
[93]汪灏,余佩武,赵永亮,等.自体树突状细胞疫苗诱导胃癌患者术后肿瘤特异性免疫反应的作用[J].第三军医大学学报,2006,28(5):408-410.
[94]Homma S,KikuchiT,IshijiN,et a.l Cancer immunotherapy by fusions of dendritic and tumour cells and rhIL-12[J].Eur JClin Invest,2005,35(4):279-286.
[95]王冠庭.晚期胃癌中西医结合治疗的思睡与体会[J].中医杂志,2001,42(9):560.
[96]黄天风.黄芪的抗肿瘤作用及其免疫学机制的实验研究[J].中华临床医学研究杂志,2007,13(4):431-432
[97]陈永仲,郭仁强.黄芪皂贰甲对小鼠腹腔巨噬细胞的影响.中国药理学与毒理学杂志,1998,2(4):11
[98]宁康健,阮样春,吕锦芳.黄芪对小鼠腹腔巨噬细胞吞噬能力的影响[J].中国中药杂志,2005,30(21):1670-167
[99]江德清,沈文梅,田亚平等.黄芪总黄酮对犬模拟肺癌术中放疗抗辐射损伤作用研究.中华放射医学与防护杂志,1996,16(6):399
[100]董晓辉,董竟成.黄芪注射液增强树突细胞的抗肺癌作用[J].中国实验方剂学杂志,2005,11(1):25-28.
[101]郑虎占,董涌起宏,佘靖等.中药现代研究与应用.第4卷.学苑出版社
[102]单颖,姜东,潘兴瑜等.玉竹多糖对衰老模型鼠免疫功能的影响.中国老年学杂志,2007,1(27):20-21
[103]李尘远,潘兴瑜,刘辉.玉竹提取物B抗肿瘤机制的初步研究.中国免疫学杂志.2003,19(4):253-254
[104]林志彬.灵芝抗肿瘤活性和免疫调节作用的研究进展.北京大学学报,2002,34,(5):493-497
[105]张闯,李长国,张旗军.薏苡仁酯对荷瘤小鼠Na~+/K~+-ATPase活性的影响[J].黑龙江中医药,2000,13(2):89.
[106]杨骅,王仙平,郁琳琳等.榄香烯抗癌作用与诱发肿瘤细胞凋亡[J].中华肿瘤杂志 1996,18(3):169
[107]李应东,李啸红,魏道武,等.莪术对硫酸镍诱发大鼠鼻咽癌前病变的影响[J].癌症.1995,14(6):460
[108]高凯民,周玲,陈金英,等.仙鹤草煎剂对HL-60 细胞的体外诱导凋亡作用[J].中药材,2000,23(9):561-562.
[109]袁静,王元勋,侯正明,等.仙鹤草鞣酸体外对人体肿瘤细胞的抑制作用[J].中国中医药科技,2000,7(6):378-379.
[110]吴琳华,郭劲柏,刘红梅,等.仙鹤草注射液对人癌细胞生长抑制作用的研究[J].中国中医药科技,2005,12(5):297-298.
[111]丁维俊,张天娥,王宇,等.仙鹤草抗癌活性成分及机理探讨[J].辽宁中医杂志,2006,33(22):251-252.
[112]李宝文,刘丽梅,王丽杰.仙鹤草对小鼠体液免疫的研究[J].辽宁药物与临床,2002,5(6):15-16
[113]曹勇,骆永珍.仙鹤草对荷瘤小鼠IL-2活性影响的研究[J].中国中医药科技,1999,(4):24
[114]金在久.仙鹤草的化学成分及临床研究进展[J].华西药学杂志,2006,21(5):469
[115]陈凌云,杨国祥.半夏药理研究概况[J].云南中医学院学报,1997,20(4):17-19.
[116]周金黄.中药药理学[M].上海:上海科技出版社.1986:125-126
[117]单保恩,张金艳,杜肖娜,等.白花蛇舌草的免疫学活性和抗肿瘤活性[J].中国中西医结合杂志,2001,21(5):370-374.
[118]李瑞,张金艳,杜肖娜,等.白花蛇舌草水溶性提取物的抗肿瘤作用和对化疗损伤的保护作用的研究[J].中国药学,2002,11(2):58
[119]雅达斌,李少钦.白花蛇舌草激活肿瘤细胞产生超氧化物和激活半胱氨酸天冬氨酸蛋白酶诱导肿瘤细胞凋亡[J].中西医结合学报,2006,4(5):485-489
[120]UICC,胃癌TNM分期[M].1997,第5版
[121]Gotay CL,Korn EL,Mary S,et al.癌症治疗方案中的生活质量评价方案发展的研究论题.国外医学肿瘤分册,1993,20(2):107
[122]洪明晃主编.科研设计测量评价.广州:中山大学出版社,1994:76
[123]万崇华,罗家洪.癌症患者生命质量测定与应用[M].第一版.北京:科学技术出版社,2007
[124]董宣,李天霖,王滨燕,等.生活质量评价-一种多维的健康评价方法.国外医学社会医学分册,1996,13(3):118
[125]Hussein MR,Haeme AK,Wood GS.Apoptosis and melanoma:molecular mechanisms.J Phathol,2003,199(3):275-288.
[126]王晓华.芪竹方诱导人胃癌细胞MGC-803凋亡和影响端粒酶及其hTERT基因蛋白表达的研究[D]2006.
[127]司徒镇强,吴军正主编.细胞培养.西安.世界图书出版公司,1996.
[128]Spugnini EP,Campioni M,DAvino A,et al.Cell-cycle molecules in meso the lioma:an overview.J Exp Clin Cancer Res.2007;26(4):443-449.
[129]Collins K,JacksT,Paveltich NP.The cell cycle and cancer.Proc Nail Acad Sci USA.1997;94:2776-2778.
[130]Malumbres M.Cyclins and related kinases in cancer cells.J BUON.2007,12(1):S45-S52.
[131]Lemos PA,Serruys PW,van Domburg RT,et al.Post-sirolimus-elutingstent restession treated with repeat percutaneous intervention:late anglo-graphic and clinical outcomes[J]Circulation,2004,109(21):2500-2.
[132]Sengupta A,Ghosh S,Bhattacharjee S.Allium vegetables in cancer prevention an overview.Asian Pac J Cancer Prey 2004;5:237-245
[133]沈冰冰,高善玲.细胞凋亡与胃癌哈尔滨医科大学学报[J].2001,35(1):75-77.
[134]]Kerr JF,Wyllie AH,Currie AR.Apoptosis:a basic biological phenomenon with wide-ranging implications in tissue kinetics.British Journal of Cancer,1972,26(4):239-257
[135].Green DR,Apoptotic pathways:the roads to ruin.Cell,1998,94(6):695.
[136]赵文丽.细胞凋亡及其检测技术的进展.山西职工医学院学报[J].2004.14(2):68-69
[137]阮红梅,张奇亚.流式细胞术在细胞凋亡研究中的应.动物医学进展[J],2005,26(3):12-15
[138]Green DR,Reed JC.Mitochondria and apoptosis Science[J].Seience,1998,281(5381):1309-1302.
[139].Bruno Antonsson. Mitochondria and the bcl-2 family Proteins in apoptosis signaling Pathways, Molecular and Cellular Biochemistry,2004;256/257:141-155,
[140]Hai N Jr. Mitochondria: A novel target for the chemo Prevention of cancer [J].Apoptosis, 2005, 10(4): 687-705
[141]Wang XD. The expanding role of mitochondria in apoptosis [J]. Genes Dev, 2001,15(11): 2922-2933.
[142]Gottlieb RA.Mitochondria:execution central[J]. FEBS Lett,2000;482:6-12
[143]Green DR,Reed Jc.Mitochondria and apoptosis [J].Science,1998,281(5381):1309-1312
[144]Fall C,Bennetl JJ. Visualization of cyclosporion A and ca2+-sensitive cycli calmito chondrial depolarization in cell culture [J] Biochim, BioPhys Acta, 1999,1410(1): 772-784.
[145]Li K,Li Y,Shelton J M, et al. Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis[J].Cell,2000,101(4):389-399.
[146]Acehan D, Jiang X, Morgan DG,et al. Three-dimensional structure of the apoptosome:implications for assembly,procaspase-9 binding and activation[J].Mol Cell,2002,9(2):423-432.
[147]Jiang X, Wang X. Cytochrome c promotescaspase-9 activation by inducing nucleotide binding to Apaf-1[J].J BiolChem, 2000, 275(40): 31199-31203.
[148]Barros M H, Netto E S, Kowuhowski A.H2O2 generation in saccharomy cescevevisiac respirtory pet mutans: effect ofcytochrome c [J]. Biol Med, 2003,35(2): 179-188.
[149]Shih C M, Ko W C, Wu J S, et al. Mediating of caspase-independent apoptosis by cadmium through the mitochondria-ROS pathway in MRC-5fibroblasts[J].Cell Biochem, 2004, 91(2): 384-397.
[150]Ricci J E, Munoz-Pinedo C, Fitzgerald P, et al. Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain[J].Cell,2004,117(6):773-786.
[151]Saito M, Korsmeyer SJ, Schlesinger PH.BAX-dependent transport of cytochrome c reconstituted in pure liposomes [J]. Nat Cell Biol, 2000, 2(8):553-555.
[152]Leu J I, Dumont P, Hafey M, et al. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcll complex[J].Nat Cell Biol,2004,6(5):443-450.
[153]Cheng E H, Wei M C, Weiler S, et al.BCL-2, BCL-X(L)sequester BH3 domain-only molecules preventing BAX-and BAK-mediated mitochondrial apoptosis[J].Mol Cell,2001,8(3):705-711.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |